Literature DB >> 1895403

Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo.

S Terré1, M A Petit, C Bréchot.   

Abstract

Generation of replicative defective viruses is frequently observed during viral infections. We now report that encapsidation and reverse transcription of spliced viral RNA is an additional mechanism for synthesis of defective viral particles. We have investigated the in vivo synthesis of a spliced hepatitis B virus (HBV) RNA. By using the polymerase chain reaction with different sets of primers on DNA purified from infected livers and the HepG2 HBV cell line, we detected a subgenomic HBV DNA complementary to the spliced viral RNA. Its nucleotide sequence was found to be identical to that previously described for the spliced RNA. This HBV RNA is packaged and reverse transcribed in vivo, the cDNA being incorporated into circulating particles. This finding establishes the synthesis of spliced HBV RNA in vivo and indicates that its reverse transcription can give rise to defective viruses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895403      PMCID: PMC249055     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  The LTR, v-src, LTR provirus generated in the mammalian genome by src mRNA reverse transcription and integration.

Authors:  J Bodor; J Svoboda
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

2.  The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.

Authors:  R Bartenschlager; M Junker-Niepmann; H Schaller
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infections.

Authors:  R H Miller; R Girones; P J Cote; W E Hornbuckle; T Chestnut; B H Baldwin; B E Korba; B C Tennant; J L Gerin; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection.

Authors:  A Tran; D Kremsdorf; F Capel; C Housset; C Dauguet; M A Petit; C Brechot
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus.

Authors:  A D Friedman; S J Triezenberg; S L McKnight
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

6.  Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 cells.

Authors:  H L Wu; P J Chen; S J Tu; M H Lin; M Y Lai; D S Chen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.

Authors:  P Paterlini; G Gerken; E Nakajima; S Terre; A D'Errico; W Grigioni; B Nalpas; D Franco; J Wands; M Kew
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

8.  Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions.

Authors:  M A Adam; A D Miller
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

Authors:  M Junker-Niepmann; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  Site-specific deletion in cauliflower mosaic virus DNA: possible involvement of RNA splicing and reverse transcription.

Authors:  H Hirochika; H Takatsuji; A Ubasawa; J E Ikeda
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more
  32 in total

Review 1.  Hepatitis B virus replication.

Authors:  Juergen Beck; Michael Nassal
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  A splice hepadnavirus RNA that is essential for virus replication.

Authors:  S Obert; B Zachmann-Brand; E Deindl; W Tucker; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

3.  In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA.

Authors:  P Soussan; F Garreau; H Zylberberg; C Ferray; C Brechot; D Kremsdorf
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

4.  Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173).

Authors:  Sophie Le Pogam; Pong Kian Chua; Margaret Newman; Chiaho Shih
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.

Authors:  E Gordien; O Rosmorduc; C Peltekian; F Garreau; C Bréchot; D Kremsdorf
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus.

Authors:  Eric B Lewellyn; Daniel D Loeb
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

Review 7.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

8.  Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA.

Authors:  Josef Köck; Michael Nassal; Karl Deres; Hubert E Blum; Fritz von Weizsäcker
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1.

Authors:  M Seifer; D N Standring
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.

Authors:  Scott Preiss; Margaret Littlejohn; Peter Angus; Alex Thompson; Paul Desmond; Sharon R Lewin; Joe Sasadeusz; Gail Matthews; Gregory J Dore; Tim Shaw; Vitini Sozzi; Lilly Yuen; George Lau; Anna Ayres; Chloe Thio; Anchalee Avihingsanon; Kiat Ruxrungtham; Stephen Locarnini; Peter A Revill
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.